Introduction
============

Myopia is the most common worldwide ocular disorder. The prevalence of myopia is much higher in Asians than in Caucasians and is an especially important public health issue in Asia. In Western populations, approximately 25% of the decreased vision is caused by myopia, while in some Asian regions, such as China, Singapore, Taiwan, Japan, and Hong Kong, it accounts for 60 -- 80% of young adult decreased vision \[[@r1]\]. High myopia is an extreme form of myopia and is usually defined by the presence of an axial eye length greater than 26 mm or a refractive error of less than −6.00 diopters (D). It is usually associated with other ocular disorders such as retinal detachment, macular degeneration, cataract, and glaucoma. For this reason, it is often designated as "pathologic" myopia. High myopia is the fourth most common cause of irreversible blindness \[[@r2]\]. In Asia, the prevalence of high myopia is 1% to 5% \[[@r3],[@r4]\], even reaching 9.1% in some regions \[[@r5]\].

High myopia is a complex disease associated with both genetic and environmental factors. Genetic linkage studies have so far identified 18 chromosomal regions harboring myopia-related genes (MYPs). Of these candidate loci, 11 have been associated with high myopia: MYP1--5 \[[@r2],[@r6]-[@r9]\], MYP11 \[[@r10]\], MYP12 \[[@r11]\], MYP13 \[[@r12]\], MYP15 \[[@r13]\], MYP16 \[[@r14]\], and MYP18 \[[@r15]\]. In the same chromosomal regions, many candidate genes associated with high myopia have been studied, such as collagen, type I, alpha 1 (*COL1A1*) \[[@r16]\], transforming growth factor, beta 1 (*TGF beta1*) \[[@r17],[@r18]\], transforming growth factor-beta-induced factor (*TGIF*) \[[@r19]\], lumican (*LUM*) \[[@r20],[@r21]\], hepatocyte growth factor (*HGF*) \[[@r22]\], myocilin (*MYOC*) \[[@r23]\], paired box 6 (*PAX6*) \[[@r24],[@r25]\], and uromodulin-like 1 (*UMODL1*) \[[@r26]\], but none of these are now thought to be responsible for or associated with high myopia.

The genome-wide association study ([GWAS](http://en.wikipedia.org/wiki/Genome-wide_association_study)) is a powerful research tool, using single nucleotide polymorphisms (SNPs) as markers to identify susceptibility genes of many complex diseases, and it has been successfully applied to identify genetic risk factors for ocular diseases. In 2009, Nakanishi et al. \[[@r27]\] used GWAS to analyze high myopia in a Japanese population. They identified a novel susceptibility locus, [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), for pathological myopia at 11q24.1, and within a 200 kb region containing [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), they found two genes. BH3-like motif containing, cell death inducer (*BLID*) is a cell death inducer containing a BH3-like motif. It is located approximately 44-kb upstream of [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948). The other gene, *LOC399959*, is a hypothetical non-coding RNA that encompasses a 114-kb DNA in the region, and [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) is located in its second intron. Because of the complexities of associating SNPs with specific disease processes in unique ethnic populations, there is no assurance that the same associations will hold for other ethnic and/or genetically distinct populations. Therefore we genotyped [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) and 18 other tag single nucleotide polymorphisms (tSNPs) of the *BLID* and *LOC399959* genes to determine if they were associated with high myopia in a Chinese population.

Methods
=======

Subjects
--------

This study was approved by Wenzhou Medical College and by local hospital ethics committees and conducted in accordance with the Declaration of Helsinki principles. All of the subjects for this study were of the Han population from the southern regions of China. They were recruited at the Eye Hospital of Wenzhou Medical College and at local hospitals and informed consent was obtained from each one. The subjects were given complete ophthalmoscopic examinations by local ophthalmologists, including measurements of visual acuity (Topcon RM-8800; Topcon Corp., Tokyo, Japan), axial length (Zeiss IOL Master; Carl Zeiss Meditec, Jena, Germany), spherical refractive error (KOH3 Keratometer; Nikon, Tokyo, Japan), and fundus photography (Canon CR6--45NM Fundus Camera; Canon Inc., Tokyo, Japan).

Individuals with high myopia had a spherical refractive error of less than −6.00 D in at least one eye and/or an axial length greater than 26 mm. Potential subjects with other known ocular or systemic diseases such as Stickler and Marfan's syndromes were excluded. Controls were recruited and met the following criteria: (1) had no known ocular disease or other genetic diseases or systemic connective tissue disorders associated with myopia, (2) were without family history of high myopia, (3) had spherical refractive error ranging from −0.50 to +2.00 D, and (4) had axial lengths less than 24 mm in both eyes.

DNA extraction
--------------

Genomic DNA was extracted from peripheral blood cells using QIAamp DNA Blood Mini Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's protocol. Briefly, 20 μl Qiagen Protease, 200 μl whole blood, and 200 μl AL Buffer was added to 1.5 ml microcentrifuge tube, respectively. The admixture was blended by pulse-vortexing and incubated at 56 °C for 10 min, then added 200 μl ethanol (96--100%) to mixture, centrifuged at 6,000× g (8,000 rpm) for 1 min, opened the QIAamp spin column and added 500 μl Buffer AW1, centrifuged at 6,000× g (8,000 rpm) for 1 min, added 500 μl Buffer AW2, centrifuged at 20,000× g (14,000 rpm) for 1 min. The isolated DNA was eluted in TE buffer (10 mM Tris-HCl, 0.5 mM EDTA, pH 9.0), and the A~260~/A~280~ optical density was measured by NanoDrop ND1000 (Thermo Fisher Scientific, Waltham, MA). It was then stored at −80 °C before use.

SNP selection and genotyping
----------------------------

To determine the association between the SNPs and the high myopic subjects, we used the tag single nucleotide polymorphisms (tSNPs) approach. The tSNPs of the *BLID* and *LOC399959* genes were selected from the public [Single Nucleotide Polymorphism](http://www.ncbi.nlm.nih.gov/SNP/) database build 126 and the phase data of the [HapMap](http://www.hapmap.org) Project release 27. Each tSNP met the following criteria: r^2^\>0.8 and minor allele frequency (MAF)\>10% in the Chinese Han population \[[@r28],[@r29]\]. We selected 19 tSNPs to tag the linkage disequilibrium (LD) blocks harbored within and surrounding the *BLID* and *LOC399959* genes ([Table 1](#t1){ref-type="table"}).

###### tSNP Genotyping of the *BLID*and *LOC399959*genes in high myopia and control subjects.

  tagSNPs                                                                          Major allele   Freq of case   Freq of control   p value   OR (95% CI)        P~permutation~\*
  -------------------------------------------------------------------------------- -------------- -------------- ----------------- --------- ------------------ ------------------
  [rs512932](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=512932)       G              0.2500         0.2400            0.6209    0.93 (0.71-1.22)   1.0000
  [rs531897](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=531897)       C              0.3365         0.3297            0.9517    0.99 (0.77-1.26)   1.0000
  [rs547008](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=547008)       T              0.2400         0.2365            0.6875    0.94 (0.72-1.23)   1.0000
  [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948)       A              0.4801         0.5054            0.5813    0.93 (0.74-1.17)   1.0000
  [rs638742](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=638742)       C              0.4329         0.4314            0.4008    1.10 (0.87-1.39)   0.9978
  [rs657514](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=657514)       C              0.4316         0.4388            0.5696    1.06 (0.85-1.34)   1.0000
  [rs664409](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=664409)       T              0.3029         0.3455            0.1797    0.84 (0.65-1.08)   0.9058
  [rs683185](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=683185)       A              0.2787         0.2996            0.4131    0.89 (0.69-1.16)   0.9984
  [rs947893](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=947893)       C              0.3222         0.3321            0.5805    0.93 (0.72-1.19)   1.0000
  [rs1143770](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1143770)     C              0.4609         0.4532            0.6015    0.94 (0.75-1.18)   1.0000
  [rs1615327](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1615327)     G              0.4948         0.4820            0.8354    1.02 (0.81-1.29)   1.0000
  [rs1816158](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1816158)     C              0.3936         0.3778            0.9546    0.99 (0.78-1.25)   1.0000
  [rs1971734](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1971734)     G              0.2808         0.2392            0.2182    1.18 (0.90-1.53)   0.9467
  [rs2241490](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2241490)     T              0.3424         0.3058            0.1217    1.22 (0.94-1.58)   0.7896
  [rs6589913](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6589913)     T              0.2364         0.2284            0.4109    1.12 (0.85-1.48)   0.9983
  [rs7119477](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7119477)     C              0.3122         0.3370            0.1328    0.81 (0.63-1.06)   0.8183
  [rs10790486](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10790486)   G              0.4102         0.4152            0.3439    0.88 (0.69-1.13)   0.9935
  [rs11604461](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11604461)   C              0.2146         0.1715            0.0726    1.30 (0.97-1.74)   0.6041
  [rs12273515](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12273515)   G              0.4292         0.4478            0.9673    1.00 (0.79-1.26)   1.0000

The asterisk indicates that 50,000 permutations were performed. In the Table, OR indicates odds ratio and CI indicates confidence interval.

DNA samples were initially diluted to \~10 ng/µl as measured with PicoGreen Dye (Invitrogen, Carlsbad, CA) in a NanoDrop ND3300 fluorospectrometer (Thermo Fisher Scientific, Waltham, MA). The tSNPs of the *BLID* and *LOC399959* genes were genotyped on MassArray platform using iPlex chemistry (Sequenom Inc., San Diego, CA) according to the manufacturer's instruction. Loci with a call rate \>0.8 were selected for association analysis on [PLINK](http://pngu.mgh.harvard.edu/~purcell/plink/) 1.07 and haplotype analysis on [Haploview](http://www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview) 4.1 \[[@r30]\].

For clinical data, means and standard errors of the means were determined. We evaluated the allele frequencies of sequence alterations in patients and controls using χ^2^ tests in a logistic regression model where age and gender were included as covariates. Allelic frequencies of detected SNPs in controls were also assessed for Hardy--Weinberg equilibrium. We also performed haplotype association analysis on [Haploview](http://www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview) 4.1 using χ^2^ tests. P-values of both single SNPs and haplotypes were corrected using permutation test after running 50,000 times.

Results
=======

Clinical data
-------------

Bilateral high myopia was present in 476 subjects (177 men, 299 women) with a mean age of 36.8±0.7 years (range: 5--77 years), and the age of onset was 14.3±0.5 years. There were 275 control subjects (152 men; 123 women) with an age of 22.3±0.3 years (range: 17--59 years). For subjects with high myopia, the spherical refractive errors of the right and left eyes were −15.05±-0.28 D and −14.57±-0.31 D, respectively. The axial lengths of the right and left eyes were 29.83±0.12 mm and 29.55±0.14 mm, respectively.

Association analysis
--------------------

After tSNP analysis of the *BLID* and *LOC399959* genes, none of the nineteen tested tSNPs demonstrated significant association with high myopia ([Table 1](#t1){ref-type="table"}). Eighteen, including [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), failed to reach a nominal significant level (p=0.05). One tSNP, [rs11604461](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11604461), was nearly significant (p=0.07, [Table 1](#t1){ref-type="table"}), but the permutation test (Ppermutation=0.6041, [Table 1](#t1){ref-type="table"}) showed it was not a true association. Thus, the results of genotyping indicated that there were no significant differences in the tSNPs between high myopia and controls in the tested region.

Haplotype analysis showed that there were five LD blocks in the *BLID* and *LOC399959* cluster regions ([Figure 1](#f1){ref-type="fig"}). After removing haplotypes with frequencies less than 5%, we analyzed haplotype associations on the five blocks. After 50,000 permutations, there were no significant differences between the high myopia and control groups ([Table 2](#t2){ref-type="table"}).

![The LD patterns of the *BLID* and *LOC399959* cluster region on 11q24.1 in Chinese Han populations of high myopia.](mv-v16-1920-f1){#f1}

###### Haplotype analysis of the *BLID*and *LOC399959*genes in high myopia and control subjects.

  **Block**     **Haplotype**   **Freq**   **Freq of case**   **Freq of control**   **χ^2^**   **p value\***   **P~permutation~\*\***
  ------------- --------------- ---------- ------------------ --------------------- ---------- --------------- ------------------------
  **Block 1**                                                                                                  
                TC              0.36       0.374              0.322                 4.143      0.0418          0.5573
                CC              0.33       0.323              0.332                 0.148      0.7004          1.0000
                TT              0.32       0.303              0.346                 2.902      0.0885          0.8196
  **Block 2**                                                                                                  
                TTC             0.53       0.529              0.537                 0.078      0.7793          1.0000
                CCT             0.24       0.238              0.229                 0.144      0.7041          1.0000
                TCC             0.13       0.134              0.13                  0.06       0.806           1.0000
                CCC             0.09       0.089              0.094                 0.105      0.7465          1.0000
  **Block 3**                                                                                                  
                CT              0.43       0.428              0.424                 0.023      0.8806          1.0000
                GC              0.38       0.391              0.372                 0.529      0.4672          1.0000
                GT              0.18       0.176              0.195                 0.841      0.3591          0.9996
  **Block 4**                                                                                                  
                GT              0.44       0.429              0.448                 0.499      0.4798          1.0000
                CT              0.37       0.356              0.381                 0.952      0.3291          0.9988
                CC              0.20       0.215              0.171                 4.229      0.0397          0.5406
  **Block 5**                                                                                                  
                GC              0.5        0.483              0.535                 3.703      0.0543          0.6453
                GG              0.26       0.28               0.237                 3.392      0.0655          0.7201
                TC              0.23       0.236              0.226                 0.181      0.6709          1.0000

The asterisk indicates that differences in the estimated haplotype frequency were examined by the χ^2^ test. The double asterisk indicates that 50,000 permutations were performed.

Discussion
==========

GWAS has been used to successfully identify susceptibility SNPs and genes in many complex disorders, such as diabetes mellitus \[[@r31]\], obesity \[[@r32]\], prostatic cancer \[[@r33]\], and aged-related macular degeneration \[[@r34]-[@r36]\]. However, a key question of GWAS is whether or not the results can be replicated in subjects of different ethnicities. The aim of this study was to determine if the *BLID* and *LOC399959* genes are disease susceptibility loci for high myopia in the Chinese Han population. The SNP [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) was the first to be validated by GWAS as a high myopia susceptibility locus in Japanese subjects \[[@r27]\]. However in the Chinese Han population, we found no significant association with high myopic patients and controls by genotyping 19 tSNPs, including [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), of the *BLID* and *LOC399959* genes.

This study can be seen as the second stage of a traditional GWAS analysis. Therefore we used the [GWApower](http://www.stats.ox.ac.uk/~marchini/software.html) \[[@r37]\], a R package for assessing the power of genome-wide association studies, as the simulation tool to compare the detection power of our sample size with the previous study in a Japanese population. With the p-value threshold of 10^−6^, relative risk of 1.5, and MAF of 0.4 according to their first stage results \[[@r37]\], the power of Japanese second stage study with 533 cases and 977 controls is 0.132. That is much higher than ours at 0.018. However, the criteria for the control subjects in our study are more stringent, and our health controls enabled us to get a higher relative risk value in the current sample size. Using 1.7 as the relative risk, the power of our study reached 0.114, which means that our study has the same power to detect the association signal in *LOC399959* as in the Japanese study.

In addition, by both χ^2^ test and logistic regression, the mean ages were significantly different between our samples and the Japanese study for both cases and controls. However, this should not impact our conclusion because high myopia is an early onset disease, usually occurring no later than the puberty years. In neither study was gender distribution completely matched for case and control groups. This should also not influence the conclusions as gender is not correlated with the occurrence of high myopia.

There may be two reasons that our results do not replicate those of the Japanese study. First, high myopia is a complex disease that is associated with high genetic heterogeneity. With studies that use different recruitment criteria, the genetic background of the patients selected for analysis could differ significantly from one another. Second, study populations composed of different ethnicities will have different genetic backgrounds. For these populations, the allelic frequencies of SNPs are likely to be different.

Thus far, the results are very limited for replication studies that have attempted to verify myopia susceptibility genes identified in association studies. This is not a surprise since it is common in complex diseases that the significant association signals in one investigation appear to be negative in other analyses. There may be several reasons for such phenomena, including different genetic backgrounds between populations and minor diversity in sample collection, clinical measurement, and statistical analysis. Considering the relatively minor contribution of each genetic factor to a complex disease in comparison with Mendelian inheritance, trivial diversity may result in differences in significance for an association signal. Furthermore, various ethnic groups may have different susceptibility genes in one disease-related pathway. Therefore, although our findings did not confirm that the *BLID* and *LOC399959* genes play a genetic role in Chinese patients with high myopia, we cannot rule out the possibility that other susceptibility genes in related molecular pathways may be involved. Also, for any associated candidate gene, perhaps meta-analysis, i.e., the combination of several high myopia association studies, will be the ultimate method for determination of a true or false positive signal, as shown by recent association studies on diabetes and a few other complex diseases \[[@r38]-[@r43]\]. To reach this goal, certainly more independent association studies in various ethnicities are needed.
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